Last reviewed · How we verify
Gonal-f®: follitropin alpha
Gonal-f®: follitropin alpha is a Small molecule drug developed by Centre Hospitalier Chretien. It is currently FDA-approved.
At a glance
| Generic name | Gonal-f®: follitropin alpha |
|---|---|
| Sponsor | Centre Hospitalier Chretien |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin (PHASE1)
- Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin
- Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation. (PHASE3)
- Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers (PHASE1)
- PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study (PHASE4)
- Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
- NATural Ovarian Stimulation (PHASE4)
- Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gonal-f®: follitropin alpha CI brief — competitive landscape report
- Gonal-f®: follitropin alpha updates RSS · CI watch RSS
- Centre Hospitalier Chretien portfolio CI
Frequently asked questions about Gonal-f®: follitropin alpha
What is Gonal-f®: follitropin alpha?
Gonal-f®: follitropin alpha is a Small molecule drug developed by Centre Hospitalier Chretien.
Who makes Gonal-f®: follitropin alpha?
Gonal-f®: follitropin alpha is developed and marketed by Centre Hospitalier Chretien (see full Centre Hospitalier Chretien pipeline at /company/centre-hospitalier-chretien).
What development phase is Gonal-f®: follitropin alpha in?
Gonal-f®: follitropin alpha is FDA-approved (marketed).